标题
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 9, Pages 3233
出版商
MDPI AG
发表日期
2020-05-05
DOI
10.3390/ijms21093233
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthesis of N‐Carbonyl Acridanes as Highly Potent Inhibitors of Tubulin Polymerization via One‐Pot Copper‐Catalyzed Dual Arylation of Nitriles with Cyclic Diphenyl Iodoniums
- (2020) Xiaopeng Peng et al. ADVANCED SYNTHESIS & CATALYSIS
- microRNA-499a promotes the progression and chemoresistance of cervical cancer cells by targeting SOX6
- (2020) Yibing Chen et al. APOPTOSIS
- Effect of dual inhibition of histone deacetylase and phosphatidylinositol-3 kinase in Philadelphia chromosome-positive leukemia cells
- (2020) Seiichi Okabe et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Effects of TiO2 Nanoparticles on Cisplatin Cytotoxicity in Cancer Cell Lines
- (2020) Basma Salama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structure-Guided Optimization of Replication Protein A (RPA)–DNA Interaction Inhibitors
- (2020) Navnath S. Gavande et al. ACS Medicinal Chemistry Letters
- Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
- (2020) Chung-Pu Wu et al. Cancers
- Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
- (2020) Sabrina Dallavalle et al. DRUG RESISTANCE UPDATES
- Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4‑mediated ferroptosis
- (2019) Xiaofen Pan et al. Oncology Letters
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients
- (2019) Chodimella Chandrasekhar et al. Scientific Reports
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
- (2019) Hideaki Ogiwara et al. CANCER CELL
- Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis
- (2019) Mohamed Elgendy et al. CANCER CELL
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs
- (2019) Ubaldo Gioia et al. Scientific Reports
- A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
- (2019) Jessica L. Wojtaszek et al. CELL
- Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion
- (2019) Yutong Liu et al. FREE RADICAL RESEARCH
- DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion
- (2019) Benjamin D. Bax et al. JOURNAL OF MOLECULAR BIOLOGY
- Reactive OFF-ON type alkylating agents for higher-ordered structures of nucleic acids
- (2019) Kazumitsu Onizuka et al. NUCLEIC ACIDS RESEARCH
- Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy
- (2019) Huanhuan Lv et al. Oxidative Medicine and Cellular Longevity
- Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
- (2019) Srinivas Patnaik et al. Frontiers in Pharmacology
- Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
- (2019) Peng Zhang et al. Frontiers in Genetics
- Fibroblast Growth Factor Receptor Functions in Glioblastoma
- (2019) Ana Jimenez-Pascual et al. Cells
- Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study
- (2019) Ya-Chen Tina Shih et al. Lancet Haematology
- AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
- (2019) Jacqueline H. L. Fok et al. Nature Communications
- Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy
- (2019) Enrico Desideri et al. Nutrients
- Computer‐aided drug design of small molecule inhibitors of the ERCC1‐XPF protein–protein interaction
- (2019) Francesco Gentile et al. Chemical Biology & Drug Design
- Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate
- (2019) Sarah Snyder et al. JOURNAL OF CONTROLLED RELEASE
- Drug metabolizing enzymes and their inhibitors' role in cancer resistance
- (2018) Shelly Pathania et al. BIOMEDICINE & PHARMACOTHERAPY
- Glutathione in Ovarian Cancer: A Double-Edged Sword
- (2018) Sofia Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Evaluation of chalcones as inhibitors of glutathione S-transferase
- (2018) Muhammet Serhat Özaslan et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Glutathione metabolism in cancer progression and treatment resistance
- (2018) Ankita Bansal et al. JOURNAL OF CELL BIOLOGY
- Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences
- (2018) Lorena Infante Lara et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
- (2018) Hui-Ming Lin et al. Scientific Reports
- Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells
- (2018) Amila K. Nanayakkara et al. Scientific Reports
- A Study on Effect of Oxaliplatin in MicroRNA Expression in Human Colon Cancer
- (2018) Jasmine Evert et al. Journal of Cancer
- Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5
- (2018) Young-Sun Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells
- (2018) Iva Guberović et al. Scientific Reports
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- Anticancer Activity of Natural Compounds from Plant and Marine Environment
- (2018) Anna Lichota et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes
- (2018) Michael J. Osborne et al. JOURNAL OF MOLECULAR BIOLOGY
- Taxifolin Resensitizes Multidrug Resistance Cancer Cells via Uncompetitive Inhibition of P-Glycoprotein Function
- (2018) Hsiu-Ju Chen et al. MOLECULES
- MicroRNA-495-3p inhibits multidrug resistance by modulating autophagy through GRP78/mTOR axis in gastric cancer
- (2018) Sheng Chen et al. Cell Death & Disease
- Tumor-related interleukins: old validated targets for new anti-cancer drug development
- (2017) Sarra Setrerrahmane et al. Molecular Cancer
- Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin
- (2017) Zeting Yuan et al. ONCOLOGY REPORTS
- Inhibition of human erythrocyte glutathione S-transferase by some flavonoid derivatives
- (2017) Mine Aksoy et al. Toxin Reviews
- Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling
- (2017) Xu-Wei Zhou et al. Oncotarget
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
- (2017) Pin-Fang He et al. Oncotarget
- Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
- (2017) Kinrin Yamanaka et al. PLoS Genetics
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine
- (2017) Yan Li et al. Scientific Reports
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein
- (2016) Xiaoyan Ying et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression
- (2016) Jing Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma
- (2016) Judith G. Villablanca et al. PEDIATRIC BLOOD & CANCER
- Pharmacogenomics and histone deacetylase inhibitors
- (2016) Andrew KL Goey et al. PHARMACOGENOMICS
- Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
- (2016) Jiang Zhu et al. Cell Death & Disease
- MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
- (2016) Z Fan et al. Oncogenesis
- MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells
- (2016) Weibin Wang et al. Scientific Reports
- Human ABCB1 confers cells resistance to cytotoxic guanidine alkaloids from Pterogyne nitens
- (2015) Kazuhiro Satake et al. BIO-MEDICAL MATERIALS AND ENGINEERING
- Chemical inhibitor targeting the replication protein A–DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer
- (2015) Akaash K. Mishra et al. BIOCHEMICAL PHARMACOLOGY
- Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF
- (2015) Timothy M. Chapman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
- (2015) Lin Lu et al. BIOTECHNOLOGY LETTERS
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL
- (2015) Paloma S. Souza et al. EXPERIMENTAL CELL RESEARCH
- Exploiting a novel miR-519c–HuR–ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer
- (2015) Kenneth K.W. To et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
- (2015) Leticia De Mattos-Arruda et al. Oncotarget
- The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
- (2015) Frank P. Vendetti et al. Oncotarget
- MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin
- (2015) Zhiyu Wang et al. Oncotarget
- Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970
- (2015) Amy B. Hall et al. Oncotarget
- Indirect modulation of sensitivity to 5-fluorouracil by microRNA-96 in human colorectal cancer cells
- (2014) Sun-Ah Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors
- (2014) T. Shimizu et al. CLINICAL CANCER RESEARCH
- Targeting DNA repair pathways for cancer treatment: what’s new?
- (2014) Mark R Kelley et al. Future Oncology
- Multiple roles of extracellular fibroblast growth factors in lung cancer cells
- (2014) TAKAHIRO SUZUKI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen(PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin
- (2014) Akira Inoue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
- (2014) Nada Albarakati et al. Molecular Oncology
- Effects of P-Glycoprotein and Its Inhibitors on Apoptosis in K562 Cells
- (2014) Yaqiong Zu et al. MOLECULES
- The role of ABC transporters in anticancer drug transport
- (2014) Serhan KARVAR TURKISH JOURNAL OF BIOLOGY
- Glutathione S-conjugates as prodrugs to target drug-resistant tumors
- (2014) Emma E. Ramsay et al. Frontiers in Pharmacology
- A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
- (2014) David A. Alagpulinsa et al. Frontiers in Oncology
- P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway
- (2013) Hanan Galski et al. BIOCHEMICAL PHARMACOLOGY
- miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1
- (2013) Y Shang et al. ONCOGENE
- miRNA profiling in pancreatic cancer and restoration of chemosensitivity
- (2012) Saurabh Singh et al. CANCER LETTERS
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
- (2011) T. M. Neher et al. MOLECULAR CANCER THERAPEUTICS
- Analysis of anticancer drugs: A review
- (2011) Susanne Nussbaumer et al. TALANTA
- P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of Etoposide
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma
- (2009) Jennifer Wu et al. INVESTIGATIONAL NEW DRUGS
- Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
- (2008) Suman Lal et al. CANCER SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started